Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 51 - 100 out of 1,128

Document Document Title
WO/2011/156889A1
There is provided modulators of Nrf2 protein which comprises a compound which binds at least one of the BTB domain, IVR domain and Kelch domain of Keap1 protein, activating or inhibiting Nrf2. There is also provided pharmaceutical compos...  
WO/2011/155169A1
Provided are organic compounds that, as materials for high efficiency, high durability organic electroluminescence elements, have excellent positive hole-injection and/or -transport capabilities, are able to block electrons, are very sta...  
WO/2011/123911A1
The present invention can be used as an antitumoral medicament for testosterone-dependent tumours, in particular prostate cancer. The invention is a molecular compound formed by testosterone molecules chemically linked to molecules of a ...  
WO/2011/127406A2
The present disclosure is directed to compounds of Formula I: which are inhibitors of Haspin kinase and DYRK kinases. The compounds of the present disclosure, and compositions thereof, are useful in the treatment of disease related to Ha...  
WO/2011/127406A3
The present disclosure is directed to compounds of Formula I: which are inhibitors of Haspin kinase and DYRK kinases. The compounds of the present disclosure, and compositions thereof, are useful in the treatment of disease related to Ha...  
WO/2011/105700A1
Provided are novel organic electroluminescent compounds, and organic electroluminescent devices comprising the same. Since the organic electroluminescent compounds exhibit high luminous efficiency in blue color, and excellent life proper...  
WO/2011/099606A1
A photoelectric element includes a conductive layer, an organic photoelectric layer, a blocking layer and a transparent conductive layer, the organic photoelectric layer contains a p type organic photoelectric material having a glass tra...  
WO/2011/093603A1
Provided are a novel organic electroluminescent compound and an organic electroluminescent device using the same. Since the organic electroluminescent compound exhibits good luminous efficiency and excellent life property, it may be used...  
WO/2011/086178A1
The present invention concerns the discovery of new selective inhibitors of ubiquitin specific proteases, their process of preparation and their therapeutic use.  
WO/2011/070177A3
Disclosed are compounds and methods for treating neurological and other disorders by administering to a subject in need thereof an effective amount of a compound having binding and/or modulation specificity for GFRα receptor molecules, ...  
WO/2011/070177A2
Disclosed are compounds and methods for treating neurological and other disorders by administering to a subject in need thereof an effective amount of a compound having binding and/or modulation specificity for GFRα receptor molecules, ...  
WO/2011/062182A1
Provided are a photo-acid generator having good development properties and a cation polymerization initiator having good curing properties, and also provided are a resist composition and cation polymerizable composition that use the phot...  
WO/2011/060228A1
Hydrophilic, chemiluminescent acridinium compounds containing zwitterions are disclosed. These acridinium compounds, when used as chemiluminescent labels in immunochemistry assays and the like, exhibit decreased non-specific binding to s...  
WO/2011/051950A1
N-substituted 9-aminoacridine and bis-acridino derivatives containing electron- withdrawing groups (EWG) or electron-donating groups (EDG), including amino acid residues, and one-pot methods for their synthesis are disclosed. The derivat...  
WO/2011/034071A1
Disclosed is a process for producing an oxidation reaction product of an aromatic compound, which has excellent environmental load reduction performance, excellent cost reduction performance and the like. Specifically disclosed is a proc...  
WO/2010/151006A1
Provided are a novel organic electroluminescent compound and an organic electroluminescent device using the same. Since the organic electroluminescent compound disclosed herein exhibits good luminescence efficiency and excellent life pro...  
WO/2010/145696A1
The present invention relates to methods for detecting presence, or absence, of blood. Specifically, the present invention relates to methods for detecting the presence, or absence, of blood, comprising applying a solution comprising lum...  
WO/2010/147319A2
The present invention relates to an acridine derivative and to an organic electroluminescent element comprising the same. More specifically, the present invention relates to an acridine derived compound in which an acridine moiety and an...  
WO/2010/147319A3
The present invention relates to an acridine derivative and to an organic electroluminescent element comprising the same. More specifically, the present invention relates to an acridine derived compound in which an acridine moiety and an...  
WO/2010/062107A1
Provided is an electroluminescent device including an organic layer interposed between an anode and a cathode on a substrate, wherein the organic layer includes an electroluminescent layer containing one or more dopant compound(s) of for...  
WO/2010/050779A1
Provided are novel organic electroluminescent compounds, and organic electroluminescent devices and organic solar cells comprising the same. The organic electroluminescent compounds according to the present invention exhibit high luminou...  
WO/2010/045270A3
The invention provides methods and compositions for detecting and measuring the amount of autophagosomes in cells or tissues, including biopsy samples, in vitro, in situ and/or in vivo. By detecting and measuring the amount of autophagos...  
WO/2010/045270A2
The invention provides methods and compositions for detecting and measuring the amount of autophagosomes in cells or tissues, including biopsy samples, in vitro, in situ and/or in vivo. By detecting and measuring the amount of autophagos...  
WO/2009/103798A1
The application relates to cationic compounds of formula (Ia) where R1 to R9 and X- are defined as indicated in claim 1. Said compounds, some of which have not yet been described in the prior art, are suitable for coloring keratinous fib...  
WO/2009/097433A1
There are described novel rhodamine dye compounds and imaging members and imaging methods, including thermal imaging members and imaging methods, utilizing the compounds. The dye compounds exhibit a first color when in the crystalline fo...  
WO/2009/067417A1
A method is provided for N-alkylation of acridine compounds, typically with a 1,3- propane sultone alkylating reagent, in ionic liquid solvents to provide the corresponding acridinium compounds in high yeild.  
WO/2009/041519A1
An organic-inorganic composite material capable of attaining a charge-separated state enhanced in life and stability as compared with that of conventional organic-inorganic composite materials, more particularly, an organic-inorganic com...  
WO/2009/030715A1
The invention relates tosubstitutedarylsulphonylaminomethylphosphonic acid derivativesof general formula (I) wherein the groups Ra to Rf, A and Z are defined as mentioned in the specification and claims, which are suitable for preparinga...  
WO/2009/026858A1
The invention relates to the synthesis and evaluation of novel organic products as anti-parasitic, anti-fungal and anti-viral agents. More specifically, the invention relates to novel derivatives of 10-alyl- (I), 10-(3methyl-2-butenyl)- ...  
WO/2008/124749A1
The present invention relates to methods and kits for detecting an analyte in a test sample using acridinium-9-carboxylate aryl esters.  
WO/2008/109840A1
This invention is directed to, for example, compounds of formula (I): wherein n, m, R1, R2, R3, R4, R5, R6, R7 and R8 are as defined herein, as a stereoisomer, enantiomer, tautomer thereof or mixtures thereof; or a pharmaceutically accep...  
WO/2008/068540A1
The present invention relates to new phenylsulfamoyl benzamide derivatives of formula (I), wherein R1-R5 and Z are as defined in the claims, and optical antipodes or racemates and/or salts and/or hydrates and/or solvates thereof, which a...  
WO/2008/068540A8
The present invention relates to new phenylsulfamoyl benzamide derivatives of formula (I), wherein R1-R5 and Z are as defined in the claims, and optical antipodes or racemates and/or salts and/or hydrates and/or solvates thereof, which a...  
WO/2008/067055A2
Chemiluminescent acridinium esters are provided which are fast light emitting and hydrolytically stable. The chemiluminescent acridinium esters are useful labels in assays for detecting or quantifying analytes.  
WO/2008/067055A3
Chemiluminescent acridinium esters are provided which are fast light emitting and hydrolytically stable. The chemiluminescent acridinium esters are useful labels in assays for detecting or quantifying analytes.  
WO/2008/064011A1
A class of acridone compounds has been discovered that exhibits chemosensitizing and antiparasitic activity. Described herein are pharmaceutical compositions and methods for their use to treat parasitic infections, such as malaria and to...  
WO/2008/012782A3
The present invention relates to the use of a compound of formula (I): in which R1 represents a radionuclide, Ar represents an aromatic nucleus, m is an integer varying from 2 to 4, R2 and R3 represent, independently of one another, a hy...  
WO/2008/012782A2
The present invention relates to the use of a compound of formula (I): in which R1 represents a radionuclide, Ar represents an aromatic nucleus, m is an integer varying from 2 to 4, R2 and R3 represent, independently of one another, a hy...  
WO/2008/011073A3
This invention provides nuclear hormone receptor binding compounds, compositions comprising the same and methods of uses thereof in treating a variety of diseases or conditions in a subject, including, inter-alia, prostate cancer and/or ...  
WO/2008/010984A3
This invention relates to the stabilization of p53 in cells, thereby inducing eitrher cell cycle arrest or apoptosis or both and the consequence of such stabilization on the treatment of cancer. Specifically, the use of acridine and its ...  
WO/2008/004529A1
A novel fluorescent amino acid derivative that can be synthesized through a simple process and that can be excited by visible rays, especially those of blue laser light region, exhibiting high photostability; and a process for producing ...  
WO/2007/136125A1
Disclosed are: a composition for inhibiting the transcription of an extracellular matrix gene, comprising a compound having a heterocyclic ring represented by the formula (I) and an inert carrier; and others.  
WO/2007/125952A1
Disclosed is a compound represented by the formula (I) below, a pharmaceutically acceptable salt thereof, or a solvate of any of them. (I) In the formula, R1 represents an optionally substituted lower alkyl group; Y represents -S(O)n- (w...  
WO/2007/110228A1
The present invention relates to N-heterocyclic compounds of the general formulae A, B, C and D and also to their uses in electronic, optoelectronic and electroluminescent components.  
WO/2007/104695A1
Novel quinolyl and acridinylhydrazone compounds of formula (I), which present remarkable biological activity especially against the choloroquine-resistant Plasmodium falciparum strains, useful for the treatment and prevention of malaria ...  
WO/2007/092847A3
Acridinium-functionalized solid-phase supports and methods for making acridinium-functionalized solid-phase supports are disclosed. The acridinium- functionalized solid-phase supports comprise a solid phase support linked to a chemilumin...  
WO/2007/092847A2
Acridinium-functionalized solid-phase supports and methods for making acridinium-functionalized solid-phase supports are disclosed. The acridinium- functionalized solid-phase supports comprise a solid phase support linked to a chemilumin...  
WO/2007/058568A3
The invention relates to 1-alkylamino-1-desoxy-polyols and 9-oxoacridine-10-acetic acid salts of general formula (I), wherein A is (II), in which R is selected from an ethyl, propyl and butyl group, to medicinal preparations containing a...  
WO/2007/058568A2
The invention relates to 1-alkylamino-1-desoxy-polyols and 9-oxoacridine-10-acetic acid salts of general formula (I), wherein A is (II), in which R is selected from an ethyl, propyl and butyl group, to medicinal preparations containing a...  
WO2006095139A3
The present invention relates to a 3,6,9 acridine compound and optionally substituted derivatives thereof that may be useful in the treatment of cancer. The invention also provides compositions comprising the compounds and uses thereof. ...  

Matches 51 - 100 out of 1,128